Featured News

The Celiac Disease Foundation is pleased to announce the establishment of two international celiac disease research prizes to inspire a new generation of researchers whose work in celiac disease will be invaluable.

A recent study identified several biochemical abnormalities associated with testing positive for celiac disease in an antibody test. These biochemical abnormalities could be a predictor of celiac disease and become a tool to reduce delayed diagnosis.

The Celiac Disease Foundation is in discussion with a team at the University of Colorado, Denver to develop the first-ever, FDA-approved pediatric PRO (patient-reported outcome tool).

A recent study found that avoidant/restrictive food intake disorder (ARFID) is common among people with celiac disease.

Last week, Celiac Disease Foundation Patient Advocates met with the staff of their Members of Congress to advocate for expanded NIH funding for celiac disease research in FY2023, and including celiac disease in the Congressionally Directed Medical Research Programs.  

Comments submitted to U.S. Preventive Services Task Force on Draft Research Plan: Preventive Services for Food Insecurity.

On April 8 and April 9, the Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center International Symposium on Celiac Disease.

The Celiac Disease Foundation is sponsoring the Columbia University Celiac Disease Center Livestream International Symposium. Join us on Friday April 8 - Saturday April 9.

The Celiac Disease Foundation is matching donations, dollar for dollar, up to $25,000. Together we can protect those with celiac disease in crisis. 

The Celiac Disease Foundation's research grant to the University of California, Davis, funds the development of celiac disease-safe wheat varieties. Dr. Jorge Dubcovsky and Dr. Wenjun Zhang submitted the grant’s first six-month report detailing promising advances.